Mint-irbesartan/hctz Product Recall (2021-05-26)
MINT is recalling irbesartan/hydrochlorothiazide (HCTZ) medication across Canada due to product safety concerns. This drug combination is used to treat high blood pressure. The recall affects all patients in Canada who have this medication.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-05-26
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/0680506e-573c-405e-8c1f-a32610d3980c